Key result
Intraperitoneal ropivacaine with fentanyl cuts postoperative analgesic consumption by ~13% versus ropivacaine alone.
Why the study?
Does intraperitoneal ropivacaine with fentanyl improve postoperative analgesia in patients undergoing laparoscopic cholecystectomy?
RCT (n=150)
Double-blind
computer-generated table of random numbers
Does intraperitoneal ropivacaine with fentanyl improve postoperative analgesia in patients undergoing laparoscopic cholecystectomy?
Intraperitoneal instillation of ropivacaine with fentanyl significantly reduces postoperative pain intensity and total rescue analgesic consumption after laparoscopic cholecystectomy.
Answers are grounded in this paper and cite their sources.
Supports combined intraperitoneal ropivacaine-fentanyl to minimize analgesic needs after laparoscopic cholecystectomy; extends RCT evidence for multimodal intraperitoneal analgesia.
Introduction Surgical procedures have been improved to reduce trauma, morbidity, mortality and hospital stay, with consequent reduction in healthcare costs. Patients undergoing laparoscopic procedures do experience postoperative pain, especially in upper and lower abdomen and back and shoulder regions. Intraperitoneal injections of local anaesthetic have been proposed to minimize postoperative pain after laparoscopic surgery. Therefore, this randomized, placebocontrolled study was conducted to compare the effectiveness of intraperitoneal ropivacaine with or without fentanyl for postoperative analgesia after laparoscopic surgery. Materials and methods Patients were randomized into three groups (n = 50) using a computergenerated table of random numbers. All surgeries were carried out under general anaesthesia, and patients were instructed preoperatively about grading the intensity of pain in the postoperative period as per visual analogue scale and verbal rating scale. The drug was injected intraperitoneally before the removal of trocar at the end of surgery. Results Visual analogue scale scores immediately postoperatively were 44.00 ± 19.16 (vs 22.20 ± 5.06 vs 23.20 ± 8.67; p < 0.001) and at 6th hour 35.40 ± 9.52 (vs 29.40 ± 4.24 vs 27.80 ± 5.0; p < 0.001). Similarly, verbal rating scale score (2.60 ± 0.88 vs 1.96 ± 0.74 vs 1.62 ± 0.56) was signiϐicantly reduced immediately postoperatively in Group 3. At the 6th hour verbal rating scale scores were 2.32 ± 0.79 vs 1.94 ± 0.42 vs 1.80 ± 0.49, which showed signiϐicantly less pain in patients receiving ropivacaine with fentanyl. Total analgesic consumption was also signiϐicantly lower in Group 3 patients (p < 0.001) in comparison to Group 1 and Group 2. In Group 1, the total analgesic (diclofenac) consumption was 149 ± 42 mg; in Group 2, 97 ± 47 mg; and in Group 3, 84 ± 25 mg. Conclusion Intraperitoneal instillation of ropivacaine with fentanyl reduces not only the intensity of visceral, parietal and shoulder pain but also the total rescue analgesic dose consumption.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2013) conducted an RCT in Postoperative pain after laparoscopic cholecystectomy (n=150). Intraperitoneal ropivacaine with fentanyl vs. Placebo or ropivacaine alone was evaluated on Visual analogue scale scores immediately postoperatively (p=<0.001). Intraperitoneal ropivacaine with fentanyl significantly reduced total postoperative analgesic consumption compared to ropivacaine alone and placebo (84 vs 97 vs 149 mg; p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: